Peritoneal Ultrafiltration in Cardio Renal Syndrome.
Status:
Not yet recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Randomized, controlled, unblinded, adaptive design clinical trial to evaluate the safety and
efficacy of PolyCore (Polydextrin, L-Carnitine, D-xylitol) peritoneal ultrafiltration (PUF)
in patients with heart failure and reduced ejection fraction (HFrEF).